Fri, May 30, 2025
[Archive]
1- Children’s Health Research Center, Golestan University of Medical Sciences, Gorgan, Iran ; Department of Biostatistics and Epidemiology, School of Health, Golestan University of Medical Sciences, Gorgan, Iran
2- Children’s Health Research Center, Golestan University of Medical Sciences, Gorgan, Iran
3- Children’s Health Research Center, Golestan University of Medical Sciences, Gorgan, Iran ,drparhiz2014@gmail.com
2- Children’s Health Research Center, Golestan University of Medical Sciences, Gorgan, Iran
3- Children’s Health Research Center, Golestan University of Medical Sciences, Gorgan, Iran ,
Abstract: (322 Views)
Background: One of the treatment methods used for influenza is the administration of antiviral medications, including oseltamivir. This study aimed to investigate the impact of the timing of oseltamivir treatment on clinical indicators and complications in hospitalized children with influenza.
Methods: This cross-sectional study was conducted on all children diagnosed with influenza who visited Taleghani Hospital in 2024. Demographic information, clinical indicators, including oxygen saturation, fever, general condition, oral intolerance, and disease outcomes such as length of hospital stay and complications were recorded using a researcher-designed checklist. The collected data were entered into SPSS software version 23.
Results: In this study, 134 children with influenza, with a mean age of 63 ± 42 months, were examined. Among them, there were 69 males and 65 females. Fever, cough, and loss of appetite were the most prevalent symptoms, occurring in 83%, 65%, and 62% of the cases, respectively. Sore throat and eye pain were the least common symptoms, reported at 9% and 10%. A total of 87 participants received oseltamivir. The overall recovery rate was 74% in the entire study population, as well as among those who received oseltamivir, and only one death was observed.
Conclusion: Based on the results, early treatment with oseltamivir has been effective in reducing clinical symptoms of influenza in affected children. Therefore, it is advisable to initiate treatment with this medication promptly upon the admission of sick children to the hospital.
Methods: This cross-sectional study was conducted on all children diagnosed with influenza who visited Taleghani Hospital in 2024. Demographic information, clinical indicators, including oxygen saturation, fever, general condition, oral intolerance, and disease outcomes such as length of hospital stay and complications were recorded using a researcher-designed checklist. The collected data were entered into SPSS software version 23.
Results: In this study, 134 children with influenza, with a mean age of 63 ± 42 months, were examined. Among them, there were 69 males and 65 females. Fever, cough, and loss of appetite were the most prevalent symptoms, occurring in 83%, 65%, and 62% of the cases, respectively. Sore throat and eye pain were the least common symptoms, reported at 9% and 10%. A total of 87 participants received oseltamivir. The overall recovery rate was 74% in the entire study population, as well as among those who received oseltamivir, and only one death was observed.
Conclusion: Based on the results, early treatment with oseltamivir has been effective in reducing clinical symptoms of influenza in affected children. Therefore, it is advisable to initiate treatment with this medication promptly upon the admission of sick children to the hospital.
Keywords: Influenza Symptoms (Influenza, Human) (Signs and Symptoms), Antiviral Medications (Multi-Ingredient Cold, Flu, and Allergy Medications), Oseltamivir
References
1. Gaitonde DY, Moore FC, Morgan MK. Influenza: diagnosis and treatment. Am Fam Physician. 2019;100(12):751-8. [View at Publisher] [Google Scholar]
2. Fodor E, Te Velthuis AJ. Structure and function of the influenza virus transcription and replication machinery. Cold Spring Harb Perspect Med. 2020;10(9):a038398. [View at Publisher] [DOI] [PMID] [Google Scholar]
3. Ahmadi K, Gharibi Z, Gorgi R, Gouklani H. High Prevalence of Influenza A (H1N1 and H3N2) Infection in South Iran. Disease and Diagnosis. 2023;12(4):156-60. [View at Publisher] [DOI] [Google Scholar]
4. Barbieri E, Porcu G, Donà D, Cavagnis S, Cantarutti L, Scamarcia A, et al. Epidemiology and Burden of Influenza in Children 0-14 Years Over Ten Consecutive Seasons in Italy. Pediatr Infect Dis J. 2023;42(12):e440-6. [View at Publisher] [DOI] [PMID] [Google Scholar]
5. Ramos-Rincón J-M, Pinargote-Celorio H, González-de-la-Aleja P, Sánchez-Payá J, Reus S, Rodríguez-Díaz J-C, et al. Impact of influenza related hospitalization in Spain: characteristics and risk factor of mortality during five influenza seasons (2016 to 2021). Front Public Health. 2024;12:1360372. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. Abdinia B, Dastranji A, Abedini AA, Moghbel I, Mobayen G. The frequency and outcome of Influenza in children admitted to Tabriz children's training and treatment center in Northwest Iran During 2014-2019. Med J Tabriz Uni Med Sciences. 2023;45(3):224-30. [View at Publisher] [DOI] [Google Scholar]
7. Tillard C, Chazard E, Faure K, Bartolo S, Martinot A, Dubos F. Burden of influenza disease in children under 2 years of age hospitalized between 2011 and 2020 in France. J Infect. 2022;84(2):145-50. [View at Publisher] [DOI] [PMID] [Google Scholar]
8. Valenzuela-Sánchez F, Valenzuela-Méndez B, Rodríguez-Gutiérrez JF, Estella Á. Latest developments in early diagnosis and specific treatment of severe influenza infection. J Intensive Med. 2023;4(2):160-74. [View at Publisher] [DOI] [PMID] [Google Scholar]
9. Uyeki TM. Oseltamivir treatment of influenza in children. Clin Infect Dis. 2018;66(10):1501-3. [View at Publisher] [DOI] [PMID] [Google Scholar]
10. Yang J-H, Huang P-Y, Shie S-S, Yang S, Tsao K-C, Wu T-L, et al. Predictive symptoms and signs of laboratory-confirmed influenza: a prospective surveillance study of two metropolitan areas in Taiwan. Medicine (Baltimore). 2015;94(44):e1952. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Mattila JM, Vuorinen T, Waris M, Antikainen P, Heikkinen T. Oseltamivir treatment of influenza A and B infections in infants. Influenza Other Respir Viruses. 2021;15(5):618-24. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Fonteles CS. Pediatric Considerations in Clinical Pharmacology. Contemporary Dental Pharmacology: Evidence-Based Considerations: Springer;2024. p.123-44. [View at Publisher] [DOI] [Google Scholar]
13. Zaheer HA, Moehling Geffel K, Chamseddine S, Liu H, Williams JV, Martin JM, et al. Factors associated with nonprescription of oseltamivir for infant influenza over 9 seasons. J Pediatric Infect Dis Soc. 2024;13(9):466-74. [View at Publisher] [DOI] [PMID] [Google Scholar]
14. Mortada M, Neuenschwander P, Tekko SS. Influenza and oseltamivir phosphate (Tamiflu) in infants: what you need to know. Pediatr Nurs. 2014;40(1):16-20. [View at Publisher] [PMID] [Google Scholar]
15. Malosh RE, Martin ET, Heikkinen T, Brooks WA, Whitley RJ, Monto AS. Efficacy and safety of oseltamivir in children: systematic review and individual patient data meta-analysis of randomized controlled trials. Clinical Infectious Diseases. 2018;66(10):1492-500. [View at Publisher] [DOI] [PMID] [Google Scholar]
16. Whitley RJ, Hayden FG, Reisinger KS, Young N, Dutkowski R, Ipe D, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J. 2001;20(2):127-33. [View at Publisher] [DOI] [PMID] [Google Scholar]
17. Heinonen S, Silvennoinen H, Lehtinen P, Vainionpää R, Vahlberg T, Ziegler T, et al. Early oseltamivir treatment of influenza in children 1-3 years of age: a randomized controlled trial.Clin Infect Dis. 2010;51(8):887-94. [View at Publisher] [DOI] [PMID] [Google Scholar]
18. Walsh PS, Schnadower D, Zhang Y, Ramgopal S, Shah SS, Wilson PM. Association of early oseltamivir with improved outcomes in hospitalized children with influenza, 2007-2020. JAMA Pediatr. 2022;176(11):e223261. [View at Publisher] [DOI] [PMID] [Google Scholar]
19. Qin J, Lin J, Zhang X, Yuan S, Zhang C, Yin Y. Evaluation of the clinical effectiveness of oseltamivir for influenza treatment in children. Front Pharmacol. 2022;13:849545. [View at Publisher] [DOI] [PMID] [Google Scholar]
20. Lim JK, Kilgore PE, Aiello AE, Foxman B, Letson GW, Jang GY, et al. Impact of time to treatment of oseltamivir on influenza hospitalization cost among K orean children. Pediatr Int. 2015;57(3):393-400. [View at Publisher] [DOI] [PMID] [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
